U.S. OKs Glaxo's cervical cancer shot (Reuters)

Reuters - GlaxoSmithKline Plc won U.S. approval on Friday to sell a cervical cancer vaccine for girls and young women, while a rival Merck & Co shot was cleared for preventing genital warts in males.